Smith Anderson advised Wolfspeed on the deal. Wolfspeed (NYSE: WOLF), the world’s largest producer of silicon carbide technology, has signed a non-binding Preliminary Memorandum of Terms...
Wolfspeed’s $750 Million Proposed Funding for Silicon Carbide Expansion
Ocuphire Pharma’s Acquisition of Opus Genetics
Sidley Austin represented Ocuphire Pharma, Inc. in the transaction, and Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan represented Opus Genetics Inc. Wilson Sonsini Goodrich & Rosati...
Arsenal Capital Partners’ Acquisition of Endpoint Clinical and Patient Access Businesses From Fortrea
Smith Anderson advised Fortrea on the deal. Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO) that helps make life changing therapies for patients, has...
Community Based Care Partners’ Acquisition of CustomCARE
Smith Anderson represented Community Based Care in the transaction. Community Based Care (CBC) of Morrisville, North Carolina, a leading provider of home and community-based services, has...
ZF Friedrichshafen’s Strategic Partnership with Wolfspeed
Gütt Olk Feldhaus, Pusch Wahlig Workplace Law, Simpson Thatcher , PwC Legal and Held Jaguttis advised ZF Friedrichshafen AG on the deal. Bird & Bird and...
Precision BioSciences’ Gene Editing Collaboration with Novartis
Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan advised Precision BioSciences on the deal. Precision BioSciences (Nasdaq: DTIL), a clinical stage gene editing company based in Durham,...
Catalyst Clinical Research’s Acquisition of Aptus Clinical
Bird & Bird has collaborated with U.S. law firm Smith Anderson to advise Catalyst Clinical Research LLC. The Aptus sellers were advised by the global law...
Azurity’s Acquisition of Arbor Pharmaceuticals
Wilson Sonsini Goodrich & Rosati and Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan advised Azurity on the deal while King & Spalding represented Arbor Pharmaceuticals. Azurity...